Autori: Verschraegen Claire
| Naslov | 1-year follow-up of a phase III study to compare efficacy and safety of a bevacizumab biosimilar, CT-P16, and reference bevacizumab as first-line treatment for metastatic or recurrent non-squamous non-small cell lung cancer (Meeting Abstract) |
| Autori | Verschraegen Claire Andric Zoran G ... (broj koautora 20) |
| Info | ANNALS OF ONCOLOGY, (2022), vol. 33 br. 7, Suppl. 7, str. S1024-S1025 |
| Projekat | Celltrion Inc. |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial (Article) |
| Autori | Verschraegen Claire Andric Zoran G Moiseenko Fedor Makharadze Tamta Shevnya Sergii Oleksiienko Alona Ruiz Eduardo Yanez Kim SungHyun Ahn KeumYoung Park TaeHong Park Sijin Ju Hana Ohe Yuichiro |
| Info | BIODRUGS, (2022), vol. 36 br. 6, str. 749-760 |
| Projekat | Celltrion, Inc. (Incheon, Republic of Korea) |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
